Skip to content
10-Q

Quarterly Report

ALBIREO PHARMA, INC.

0001558370-22-008984

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 9, 2022 19.58M sh
Shares Diluted Q1 2022 · Mar 31, 2022 19.38M sh
Shares Diluted Q1 2022 · Mar 31, 2021 19.13M sh
Capex Q1 2022 · Mar 31, 2022 $235K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$35.41M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$34.72M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $216.66M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $248.11M
Cash And Equivalents restated Q1 2022 · Mar 31, 2021 $216.7M
Stockholders Equity Q1 2022 · Mar 31, 2022 $148.19M
Stockholders Equity Q1 2022 · Dec 31, 2021 $175.61M
Stockholders Equity Q1 2022 · Mar 31, 2021 $147.92M
Stockholders Equity Q1 2022 · Dec 31, 2020 $181.23M
Current Liabilities Q1 2022 · Mar 31, 2022 $31.51M
Current Liabilities Q1 2022 · Dec 31, 2021 $45.35M
Total Liabilities Q1 2022 · Mar 31, 2022 $113.08M
Total Liabilities Q1 2022 · Dec 31, 2021 $126.44M
Current Assets Q1 2022 · Mar 31, 2022 $228.73M
Current Assets Q1 2022 · Dec 31, 2021 $268.93M
Total Assets Q1 2022 · Mar 31, 2022 $261.26M
Total Assets Q1 2022 · Dec 31, 2021 $302.05M
Eps Diluted Q1 2022 · Mar 31, 2022 −$2.19
Eps Diluted Q1 2022 · Mar 31, 2021 −$2.29
Eps Basic Q1 2022 · Mar 31, 2022 −$2.19
Eps Basic Q1 2022 · Mar 31, 2021 −$2.29
Sga Expense Q1 2022 · Mar 31, 2022 $16.86M
Sga Expense Q1 2022 · Mar 31, 2021 $15.27M
Rd Expense Q1 2022 · Mar 31, 2022 $21.9M
Rd Expense Q1 2022 · Mar 31, 2021 $19.94M
Net Income Q1 2022 · Mar 31, 2022 −$42.43M
Net Income Q1 2022 · Mar 31, 2021 −$43.73M
Operating Income Q1 2022 · Mar 31, 2022 −$39.56M
Operating Income Q1 2022 · Mar 31, 2021 −$39.78M
Cost Of Revenue Q1 2022 · Mar 31, 2022 $234K
Revenue Q1 2022 · Mar 31, 2022 $6.83M
Revenue Q1 2022 · Mar 31, 2021 $1.97M